Pharmacology

The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.

The FDA has approved a new buprenorphine treatment option for people with opioid use disorder following clinical trials that tested its safety and efficacy.

Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.

Did you get the chance to view our Multidisciplinary Roundtable on some hot topics in treating patients with HIV? Here are some highlights that you may have missed. 

Using a systematic review, researchers evaluated the use of low-dose combination triple and quadruple antihypertensives to manage hypertension in patients.

The FDA approved the first treatment for pediatric patients who experience functional constipation

This COVID-19 roundup includes coverage of the combination of amubarvimab and romlusevimab to manage COVID-19 infection, the association between COVID-19 and incident diabetes, and the effectiveness of...

The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.

The FDA’s approval of nalmefene hydrochloride nasal spray marks the first of its kind for health care and community use.

After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.